{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:15:29Z","timestamp":1791515729950,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"\u5b66\u8853\u632f\u8208\u4f1a"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17702-x","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T19:19:59Z","timestamp":1756495199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Choline transporter-like protein 1 in tongue squamous cell carcinoma: implications for cell proliferation and differentiation"],"prefix":"10.1038","volume":"15","author":[{"given":"Nao","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4092-3208","authenticated-orcid":false,"given":"Kei","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2262-5610","authenticated-orcid":false,"given":"Yoshihiko","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0613-6481","authenticated-orcid":false,"given":"Katsutoshi","family":"Kokubun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0260-396X","authenticated-orcid":false,"given":"Keisuke","family":"Sugahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-1267","authenticated-orcid":false,"given":"Akira","family":"Katakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Matsuzaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"17702_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3892\/ol.2014.2103","volume":"8","author":"C Rivera","year":"2014","unstructured":"Rivera, C. & Venegas, B. Histological and molecular aspects of oral squamous cell carcinoma (Review). Oncol. Lett. 8, 7\u201311 (2014).","journal-title":"Oncol. Lett."},{"key":"17702_CR2","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jds.2023.02.007","volume":"18","author":"XJ Cai","year":"2023","unstructured":"Cai, X. J., Zhang, H. Y., Zhang, J. Y. & Li, T. J. Bibliometric analysis of immunotherapy for head and neck squamous cell carcinoma. J. Dent. Sci. 18, 872\u2013882 (2023).","journal-title":"J. Dent. Sci."},{"key":"17702_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nrc3162","volume":"11","author":"K Glunde","year":"2011","unstructured":"Glunde, K., Bhujwalla, Z. M. & Ronen, S. M. Choline metabolism in malignant transformation. Nat. Rev. Cancer 11, 835\u2013848 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"17702_CR4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1586\/14737159.2015.1039515","volume":"15","author":"K Glunde","year":"2015","unstructured":"Glunde, K., Penet, M. F., Jiang, L., Jacobs, M. A. & Bhujwalla, Z. M. Choline metabolism-based molecular diagnosis of cancer: An update. Expert Rev. Mol. Diagn. 15, 735\u2013747 (2015).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"17702_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/bdd.1892","volume":"35","author":"M Inazu","year":"2014","unstructured":"Inazu, M. Choline transporter-like proteins CTLs\/SLC44 family as a novel molecular target for cancer therapy. Biopharm. Drug Dispos. 35, 431\u2013449 (2014).","journal-title":"Biopharm. Drug Dispos."},{"key":"17702_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12149-018-01325-6","volume":"33","author":"M Roppongi","year":"2019","unstructured":"Roppongi, M., Izumisawa, M., Terasaki, K., Muraki, Y. & Shozushima, M. 18F-FDG and 11C-choline uptake in proliferating tumor cells is dependent on the cell cycle in vitro. Ann. Nucl. Med. 33, 237\u2013243 (2019).","journal-title":"Ann. Nucl. Med."},{"key":"17702_CR7","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.3390\/jcm8101657","volume":"8","author":"N Urbano","year":"2019","unstructured":"Urbano, N. et al. 18F-Choline PET\/CT identifies high-grade prostate cancer lesions expressing bone biomarkers. J. Clin. Med. 8, 1657 (2019).","journal-title":"J. Clin. Med."},{"key":"17702_CR8","first-page":"1507","volume":"41","author":"T Hara","year":"2000","unstructured":"Hara, T., Inagaki, K., Kosaka, N. & Morita, T. Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET. J. Nucl. Med. 41, 1507\u20131513 (2000).","journal-title":"J. Nucl. Med."},{"key":"17702_CR9","first-page":"842","volume":"38","author":"T Hara","year":"1997","unstructured":"Hara, T., Kosaka, N., Shinoura, N. & Kondo, T. PET imaging of brain tumor with [methyl-11C] choline. J. Nucl. Med. 38, 842\u2013847 (1997).","journal-title":"J. Nucl. Med."},{"key":"17702_CR10","first-page":"990","volume":"39","author":"T Hara","year":"1998","unstructured":"Hara, T., Kosaka, N. & Kishi, H. PET imaging of prostate cancer using carbon-11Choline nd. J. Nucl. Med. 39, 990\u2013995 (1998).","journal-title":"J. Nucl. Med."},{"key":"17702_CR11","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.3892\/or.2017.5561","volume":"37","author":"M Ohshima","year":"2017","unstructured":"Ohshima, M., Sugahara, K., Kasahara, K. & Katakura, A. Metabolomic analysis of the saliva of Japanese patients with oral squamous cell carcinoma. Oncol. Rep. 37, 2727\u20132734 (2017).","journal-title":"Oncol. Rep."},{"key":"17702_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4062\/biomolther.2017.113","volume":"26","author":"F Nagashima","year":"2018","unstructured":"Nagashima, F. et al. Molecular and functional characterization of choline transporter-like proteins in esophageal cancer cells and potential therapeutic targets. Biomol. Ther. (Seoul) 26, 399\u2013408 (2018).","journal-title":"Biomol. Ther. (Seoul)"},{"key":"17702_CR13","doi-asserted-by":"publisher","first-page":"5190","DOI":"10.3390\/ijms21155190","volume":"21","author":"K Hirai","year":"2020","unstructured":"Hirai, K. et al. Molecular and functional analysis of choline transporters and antitumor effects of choline transporter-like protein 1 inhibitors in human pancreatic cancer cells. Int. J. Mol. Sci. 21, 5190 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"17702_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.phrs.2013.07.011","volume":"76","author":"M Inazu","year":"2013","unstructured":"Inazu, M., Yamada, T., Kubota, N. & Yamanaka, T. Functional expression of choline transporter-like protein 1 (CTL1) in small cell lung carcinoma cells: a target molecule for lung cancer therapy. Pharmacol. Res. 76, 119\u2013131 (2013).","journal-title":"Pharmacol. Res."},{"key":"17702_CR15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1745-7270.2007.00323.x","volume":"39","author":"T Wang","year":"2007","unstructured":"Wang, T. et al. Choline transporters in human lung adenocarcinoma: expression and functional implications. Acta. Biochim. Biophys. Sin. (Shanghai) 39, 668\u2013674 (2007).","journal-title":"Acta. Biochim. Biophys. Sin. (Shanghai)"},{"key":"17702_CR16","doi-asserted-by":"crossref","unstructured":"Watanabe, S., et al.\u00a0Anticancer activity of Amb4269951, a choline transporter-like protein 1 inhibitor, in human glioma cells.\u00a0Pharmaceuticals (Basel)\u00a013, 104 (2020).","DOI":"10.3390\/ph13050104"},{"key":"17702_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4062\/biomolther.2019.097","volume":"28","author":"I Saiki","year":"2020","unstructured":"Saiki, I., Yara, M., Yamanaka, T., Uchino, H. & Inazu, M. Functional expression of choline transporter-like protein 1 in LNCaP prostate cancer cells: a novel molecular target. Biomol. Ther. (Seoul) 28, 195\u2013201 (2020).","journal-title":"Biomol. Ther. (Seoul)"},{"key":"17702_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1600-0714.1989.tb01570.x","volume":"18","author":"F Momose","year":"1989","unstructured":"Momose, F. et al. Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas. J. Oral Pathol. Med. 18, 391\u2013395 (1989).","journal-title":"J. Oral Pathol. Med."},{"key":"17702_CR19","doi-asserted-by":"crossref","unstructured":"Shibata, K., et al.\u00a0A novel plant-derived choline transporter-like protein 1 inhibitor, amb544925, induces apoptotic cell death via the ceramide\/survivin pathway in tongue squamous cell carcinoma.\u00a0Cancers (Basel)\u00a014, 329 (2022).","DOI":"10.3390\/cancers14020329"},{"key":"17702_CR20","first-page":"685","volume":"27","author":"A Katakura","year":"1987","unstructured":"Katakura, A. et al. Induction of squamous cell carcinoma in the oral cavity of the rats by oral administration of 4-nitroquinoline 1-oxide in the drinking water (in Japanese). Jpn. J. Oral Maxillofac. Surg. 27, 685\u2013700 (1987).","journal-title":"Jpn. J. Oral Maxillofac. Surg."},{"key":"17702_CR21","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.3390\/ijms23095266","volume":"23","author":"C Stoica","year":"2022","unstructured":"Stoica, C., Ferreira, A. K., Hannan, K. & Bakovic, M. Bilayer forming phospholipids as targets for cancer therapy. Int. J. Mol. Sci. 23, 5266 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"17702_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fonc.2016.00266","volume":"6","author":"M Cheng","year":"2016","unstructured":"Cheng, M., Bhujwalla, Z. M. & Glunde, K. Targeting phospholipid metabolism in cancer. Front. Oncol. 6, 266 (2016).","journal-title":"Front. Oncol."},{"key":"17702_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.571237","volume":"8","author":"G Preta","year":"2020","unstructured":"Preta, G. New insights into targeting membrane lipids for cancer therapy. Front Cell. Dev. Biol. 8, 571237 (2020).","journal-title":"Front Cell. Dev. Biol."},{"key":"17702_CR24","doi-asserted-by":"crossref","unstructured":"Tan, L. T-H.., et al. Targeting membrane lipid a potential cancer cure? Front Pharmacol. 8, (2017).","DOI":"10.3389\/fphar.2017.00012"},{"key":"17702_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jphs.2016.04.022","volume":"131","author":"R Nishiyama","year":"2016","unstructured":"Nishiyama, R. et al. Identification and functional analysis of choline transporter in tongue cancer: A novel molecular target for tongue cancer therapy. J. Pharmacol. Sci. 131, 101\u2013109 (2016).","journal-title":"J. Pharmacol. Sci."},{"key":"17702_CR26","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1172\/JCI116367","volume":"91","author":"S Uchida","year":"1993","unstructured":"Uchida, S., Yamauchi, A., Preston, A. S., Kwon, H. M. & Handler, J. S. Medium tonicity regulates expression of the Na(+)- and Cl(-)-dependent betaine transporter in Madin-Darby canine kidney cells by increasing transcription of the transporter gene. J. Clin. Investig. 91, 1604\u20131607 (1993).","journal-title":"J. Clin. Investig."},{"key":"17702_CR27","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.2741\/2135","volume":"12","author":"G Ossani","year":"2007","unstructured":"Ossani, G., Dalghi, M. & Repetto, M. Oxidative damage lipid peroxidation in the kidney of choline-deficient rats. Front. Biosci. 12, 1174\u20131183 (2007).","journal-title":"Front. Biosci."},{"key":"17702_CR28","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1002\/ijc.33922","volume":"150","author":"Z Fan","year":"2022","unstructured":"Fan, Z. et al. Crosstalk of FGFR1 signaling and choline metabolism promotes cell proliferation and survival in prostate cancer cells. Int. J. Cancer 150, 1525\u20131536 (2022).","journal-title":"Int. J. Cancer"},{"key":"17702_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/iub.337","volume":"62","author":"F Gibellini","year":"2010","unstructured":"Gibellini, F. & Smith, T. K. The Kennedy pathway\u2013De novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life 62, 414\u2013428 (2010).","journal-title":"IUBMB Life"},{"key":"17702_CR30","doi-asserted-by":"crossref","unstructured":"Garcia, P. L., Miller, A. L. & Yoon, K. J. Patient-derived xenograft models of pancreatic cancer: Overview and comparison with other types of models.\u00a0Cancers (Basel)\u00a012, 1327 (2020).","DOI":"10.3390\/cancers12051327"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17702-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17702-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17702-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:34:23Z","timestamp":1757453663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17702-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17702"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17702-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent has been obtained from the patients who participated in the prospective study to publish this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"31927"}}